New Key Statistics Module, Z-Score and F-Score
NAS:DERM Key Ratios
Market Cap $ M | 118.28 |
Enterprise Value $ M | 106.59 |
P/E(ttm) | -- |
PE Ratio without NRI | 19.63 |
Forward PE Ratio | -- |
Price/Book | 9.09 |
Price/Sales | 1.45 |
Price/Free Cash Flow | 2,939.76 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 79.00 |
EPS (TTM) $ | -0.31 |
Beneish M-Score | -3.1 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -45.51 |
EV-to-EBITDA | 84.73 |
PEG | -- |
Shares Outstanding M | 20.01 |
Net Margin (%) | -5.20 |
Operating Margin % | 0.68 |
Pre-tax Margin (%) | -4.92 |
Quick Ratio | 0.94 |
Current Ratio | 1.21 |
ROA % (ttm) | -5.55 |
ROE % (ttm) | -35.75 |
ROIC % (ttm) | 1.49 |
Dividend Yield % | -- |
Altman Z-Score | 0.79 |
DERM Number of Guru Trades
DERM Volume of Guru Trades
Gurus Latest Trades with NAS:DERM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:DERM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Journey Medical Corp Insider Transactions
No Available Data
News about NAS:DERM
Total 0- 1